BCTXW — BriaCell Therapeutics Corp.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for BCTXW in the TickerWise workspace.

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: CA
• Exchange: NASDAQ
• Employees: 16
• Website: https://briacell.com

Latest SEC filings for BCTXW

• 2026-01-158-K
• 2026-01-14424B4
• 2026-01-13S-1MEF
• 2025-12-298-K
• 2025-12-23S-1
• 2025-12-1110-Q
• 2025-12-018-K
• 2025-10-1610-K
• 2025-08-268-K
• 2025-07-16424B4

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.